JACC: Cardiovascular Interventions, ISSN 1936-8798, 10/2014, Volume 7, Issue 10, pp. 1093 - 1102
Objectives The aim of this study was to identify clinical, procedural, and angiographic correlates of late/very late drug-eluting stent (DES) thrombosis as...
late stent thrombosis | percutaneous coronary intervention | drug-eluting stent | CARDIAC & CARDIOVASCULAR SYSTEMS | OPTICAL COHERENCE TOMOGRAPHY | BARE-METAL STENTS | SMOKING STATUS | ANTIPLATELET THERAPY | ROUTINE CLINICAL-PRACTICE | LARGE 2-INSTITUTIONAL COHORT | INTRAVASCULAR ULTRASOUND | ELEVATION MYOCARDIAL-INFARCTION | ARTERY-DISEASE | Multivariate Analysis | Coronary Thrombosis - diagnosis | Myocardial Infarction - mortality | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Male | Coronary Thrombosis - physiopathology | Prosthesis Design | Percutaneous Coronary Intervention - instrumentation | Time Factors | Female | Registries | Retrospective Studies | Drug Therapy, Combination | Odds Ratio | Platelet Aggregation Inhibitors - therapeutic use | Myocardial Infarction - etiology | Coronary Thrombosis - mortality | Drug-Eluting Stents | Hospital Mortality | Risk Assessment | Risk Factors | Logistic Models | Treatment Outcome | Coronary Artery Disease - mortality | Coronary Angiography | Coronary Artery Disease - therapy | Coronary Artery Disease - diagnosis | Aged | Coronary Thrombosis - etiology | Percutaneous Coronary Intervention - adverse effects
late stent thrombosis | percutaneous coronary intervention | drug-eluting stent | CARDIAC & CARDIOVASCULAR SYSTEMS | OPTICAL COHERENCE TOMOGRAPHY | BARE-METAL STENTS | SMOKING STATUS | ANTIPLATELET THERAPY | ROUTINE CLINICAL-PRACTICE | LARGE 2-INSTITUTIONAL COHORT | INTRAVASCULAR ULTRASOUND | ELEVATION MYOCARDIAL-INFARCTION | ARTERY-DISEASE | Multivariate Analysis | Coronary Thrombosis - diagnosis | Myocardial Infarction - mortality | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Male | Coronary Thrombosis - physiopathology | Prosthesis Design | Percutaneous Coronary Intervention - instrumentation | Time Factors | Female | Registries | Retrospective Studies | Drug Therapy, Combination | Odds Ratio | Platelet Aggregation Inhibitors - therapeutic use | Myocardial Infarction - etiology | Coronary Thrombosis - mortality | Drug-Eluting Stents | Hospital Mortality | Risk Assessment | Risk Factors | Logistic Models | Treatment Outcome | Coronary Artery Disease - mortality | Coronary Angiography | Coronary Artery Disease - therapy | Coronary Artery Disease - diagnosis | Aged | Coronary Thrombosis - etiology | Percutaneous Coronary Intervention - adverse effects
Journal Article
Neurosurgery, ISSN 0148-396X, 12/2010, Volume 67, Issue 1, pp. onsE313 - onsE314
BACKGROUND: The Pipeline embolization device (PED) is a new endoluminal construct designed to exclude aneurysms from the parent cerebrovasculature. We report...
Reconstruction | Fusiform | Very late thrombosis | Stent | Aneurysm | SURGERY | INITIAL-EXPERIENCE | FOLLOW-UP | CERECYTE COILS | CLINICAL NEUROLOGY | INTRACRANIAL ANEURYSMS | IMPLANTATION | IN-STENT STENOSIS | Intracranial Aneurysm - etiology | Vertebral Artery - surgery | Follow-Up Studies | Intracranial Aneurysm - therapy | Humans | Stroke - complications | Polyglycolic Acid - therapeutic use | Cerebral Angiography - methods | Embolization, Therapeutic - methods
Reconstruction | Fusiform | Very late thrombosis | Stent | Aneurysm | SURGERY | INITIAL-EXPERIENCE | FOLLOW-UP | CERECYTE COILS | CLINICAL NEUROLOGY | INTRACRANIAL ANEURYSMS | IMPLANTATION | IN-STENT STENOSIS | Intracranial Aneurysm - etiology | Vertebral Artery - surgery | Follow-Up Studies | Intracranial Aneurysm - therapy | Humans | Stroke - complications | Polyglycolic Acid - therapeutic use | Cerebral Angiography - methods | Embolization, Therapeutic - methods
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 05/2018, Volume 11, Issue 9, pp. 906 - 908
Journal Article
Current Opinion in Obstetrics and Gynecology, ISSN 1040-872X, 06/2009, Volume 21, Issue 3, pp. 207 - 218
Purpose of review The use of assisted reproductive technology (ART) has increased tremendously in the past three decades. During the process of ART,...
Arterial thrombosis | Ovarian hyperstimulation syndrome | Assisted reproductive technology | Venous thromboembolism | ovarian hyperstimulation syndrome | LATE COMPLICATION | assisted reproductive technology | JUGULAR-VEIN THROMBOSIS | OVULATION INDUCTION | V-LEIDEN MUTATION | OBSTETRICS & GYNECOLOGY | venous thromboembolism | FOLLICLE-STIMULATING-HORMONE | SUBCLAVIAN VEIN | IN-VITRO FERTILIZATION | arterial thrombosis | OF-THE-LITERATURE | ISCHEMIC-STROKE | Pregnancy | Reproductive Techniques, Assisted - adverse effects | Thrombosis - physiopathology | Ovarian Hyperstimulation Syndrome - complications | Thrombosis - etiology | Fibrinolytic Agents - therapeutic use | Humans | Female | Thrombosis - drug therapy | Ovarian Hyperstimulation Syndrome - physiopathology
Arterial thrombosis | Ovarian hyperstimulation syndrome | Assisted reproductive technology | Venous thromboembolism | ovarian hyperstimulation syndrome | LATE COMPLICATION | assisted reproductive technology | JUGULAR-VEIN THROMBOSIS | OVULATION INDUCTION | V-LEIDEN MUTATION | OBSTETRICS & GYNECOLOGY | venous thromboembolism | FOLLICLE-STIMULATING-HORMONE | SUBCLAVIAN VEIN | IN-VITRO FERTILIZATION | arterial thrombosis | OF-THE-LITERATURE | ISCHEMIC-STROKE | Pregnancy | Reproductive Techniques, Assisted - adverse effects | Thrombosis - physiopathology | Ovarian Hyperstimulation Syndrome - complications | Thrombosis - etiology | Fibrinolytic Agents - therapeutic use | Humans | Female | Thrombosis - drug therapy | Ovarian Hyperstimulation Syndrome - physiopathology
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 05/2018, Volume 11, Issue 9, pp. 906 - 908
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 01/2012, Volume 5, Issue 1, pp. 12 - 20
This study investigated the role of uncovered stent struts on late stent thrombosis (LST) after drug-eluting stent (DES) implantation with optical coherence...
late stent thrombosis | percutaneous coronary intervention | optical coherence tomography | acute myocardial infarction | drug-eluting stent(s) | CARDIAC & CARDIOVASCULAR SYSTEMS | COVERAGE | ACQUISITION | BARE-METAL | FOLLOW-UP | CORONARY-ARTERY | IMPLANTATION | RESTENOSIS | DOCUMENT | Multivariate Analysis | Ultrasonography, Interventional - methods | Coronary Thrombosis - diagnosis | Drug-Eluting Stents | Tomography, Optical Coherence | Humans | Middle Aged | Neutrophils | Logistic Models | Male | Ultrasonography, Interventional - instrumentation | Statistics as Topic | Coronary Restenosis - diagnostic imaging | Coronary Restenosis - pathology | Coronary Thrombosis - pathology | Case-Control Studies | Angioplasty, Balloon, Coronary | Coronary Thrombosis - diagnostic imaging | Coronary Restenosis - diagnosis | Time Factors | Female | Aged | Endothelium, Vascular | Eosinophils
late stent thrombosis | percutaneous coronary intervention | optical coherence tomography | acute myocardial infarction | drug-eluting stent(s) | CARDIAC & CARDIOVASCULAR SYSTEMS | COVERAGE | ACQUISITION | BARE-METAL | FOLLOW-UP | CORONARY-ARTERY | IMPLANTATION | RESTENOSIS | DOCUMENT | Multivariate Analysis | Ultrasonography, Interventional - methods | Coronary Thrombosis - diagnosis | Drug-Eluting Stents | Tomography, Optical Coherence | Humans | Middle Aged | Neutrophils | Logistic Models | Male | Ultrasonography, Interventional - instrumentation | Statistics as Topic | Coronary Restenosis - diagnostic imaging | Coronary Restenosis - pathology | Coronary Thrombosis - pathology | Case-Control Studies | Angioplasty, Balloon, Coronary | Coronary Thrombosis - diagnostic imaging | Coronary Restenosis - diagnosis | Time Factors | Female | Aged | Endothelium, Vascular | Eosinophils
Journal Article
Diabetes Therapy, ISSN 1869-6953, 6/2018, Volume 9, Issue 3, pp. 1113 - 1124
At this time in 2018, with type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) still on the rise, the post-percutaneous coronary interventional...
Late stent thrombosis | Medicine & Public Health | Drug-eluting stents | Early stent thrombosis | Internal Medicine | Percutaneous coronary intervention | Diabetes | Cardiology | Insulin-treated type 2 diabetes mellitus | Coronary artery disease | Endocrinology | EVEROLIMUS | PACLITAXEL-ELUTING STENTS | NONDIABETIC PATIENTS | ENDOCRINOLOGY & METABOLISM | SYNTAX SCORE | CLINICAL-OUTCOMES | ARTERY-DISEASE | Cardiovascular disease | Stents | Thrombosis | Insulin | Meta-analysis | Original Research
Late stent thrombosis | Medicine & Public Health | Drug-eluting stents | Early stent thrombosis | Internal Medicine | Percutaneous coronary intervention | Diabetes | Cardiology | Insulin-treated type 2 diabetes mellitus | Coronary artery disease | Endocrinology | EVEROLIMUS | PACLITAXEL-ELUTING STENTS | NONDIABETIC PATIENTS | ENDOCRINOLOGY & METABOLISM | SYNTAX SCORE | CLINICAL-OUTCOMES | ARTERY-DISEASE | Cardiovascular disease | Stents | Thrombosis | Insulin | Meta-analysis | Original Research
Journal Article
Current Opinion in Cardiology, ISSN 0268-4705, 11/2012, Volume 27, Issue 6, pp. 634 - 641
PURPOSE OF REVIEWDrug-eluting stents (DES) are effective in reducing neointimal proliferation and in-stent restenosis. However, the procedure is complicated by...
very late stent thrombosis | drug-eluting stent | bioabsorbable stent | myocardial infarction | CARDIAC & CARDIOVASCULAR SYSTEMS | TARGET LESION REVASCULARIZATION | VASCULAR SCAFFOLD | BARE-METAL STENTS | FOLLOW-UP | RANDOMIZED CONTROLLED-TRIAL | SIROLIMUS-ELUTING STENTS | INTRAVASCULAR ULTRASOUND FINDINGS | ROUTINE CLINICAL-PRACTICE | INCOMPLETE NEOINTIMAL COVERAGE | NATIVE CORONARY-ARTERIES | Drug-Eluting Stents | Prevalence | Time Factors | Tomography, Optical Coherence | Humans | Blood Platelets | Coronary Thrombosis - prevention & control | Ultrasonography, Interventional | Coronary Restenosis - prevention & control | Treatment Outcome | Platelet Aggregation Inhibitors - therapeutic use | Incidence
very late stent thrombosis | drug-eluting stent | bioabsorbable stent | myocardial infarction | CARDIAC & CARDIOVASCULAR SYSTEMS | TARGET LESION REVASCULARIZATION | VASCULAR SCAFFOLD | BARE-METAL STENTS | FOLLOW-UP | RANDOMIZED CONTROLLED-TRIAL | SIROLIMUS-ELUTING STENTS | INTRAVASCULAR ULTRASOUND FINDINGS | ROUTINE CLINICAL-PRACTICE | INCOMPLETE NEOINTIMAL COVERAGE | NATIVE CORONARY-ARTERIES | Drug-Eluting Stents | Prevalence | Time Factors | Tomography, Optical Coherence | Humans | Blood Platelets | Coronary Thrombosis - prevention & control | Ultrasonography, Interventional | Coronary Restenosis - prevention & control | Treatment Outcome | Platelet Aggregation Inhibitors - therapeutic use | Incidence
Journal Article
Jacc. Cardiovascular Interventions, ISSN 1936-8798, 2018, Volume 11, Issue 7, pp. 638 - 644
OBJECTIVES: The aim of this study was to identify independent correlates of very late scaffold thrombosis (VLST) from an analysis of consecutively treated...
bioresorbable scaffold | thrombosis | TRIAL | LATE STENT THROMBOSIS | ELUTING STENTS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | CORONARY-ARTERY LESIONS | PREDICTORS | DISEASE | MECHANISMS | OUTCOMES
bioresorbable scaffold | thrombosis | TRIAL | LATE STENT THROMBOSIS | ELUTING STENTS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | CORONARY-ARTERY LESIONS | PREDICTORS | DISEASE | MECHANISMS | OUTCOMES
Journal Article
JACC: Cardiovascular Imaging, ISSN 1936-878X, 2013, Volume 6, Issue 6, pp. 695 - 703
Objectives We report optical coherence tomography (OCT) findings in 33 patients who presented with very late stent thrombosis (VLST) after either drug-eluting...
Cardiovascular | very late stent thrombosis | optical coherence tomography | neoatherosclerosis | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | ATHEROSCLEROSIS | BARE-METAL | RISK | INTRAVASCULAR ULTRASOUND FINDINGS | IMPLANTATION | APPOSITION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | DRUG-ELUTING STENTS | Coronary Vessels - diagnostic imaging | Myocardial Infarction - blood | Predictive Value of Tests | Coronary Thrombosis - diagnosis | Humans | Metals | Middle Aged | Male | Prosthesis Design | Percutaneous Coronary Intervention - instrumentation | Neointima | Prosthesis Failure | Time Factors | Female | Myocardial Infarction - etiology | Stents | Myocardial Infarction - diagnosis | Coronary Vessels - pathology | Drug-Eluting Stents | Cross-Sectional Studies | Tomography, Optical Coherence | Biomarkers - blood | Chi-Square Distribution | Coronary Thrombosis - pathology | Coronary Angiography | Creatine Kinase, MB Form - blood | Aged | Coronary Thrombosis - etiology | Percutaneous Coronary Intervention - adverse effects | Rupture, Spontaneous
Cardiovascular | very late stent thrombosis | optical coherence tomography | neoatherosclerosis | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | ATHEROSCLEROSIS | BARE-METAL | RISK | INTRAVASCULAR ULTRASOUND FINDINGS | IMPLANTATION | APPOSITION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | DRUG-ELUTING STENTS | Coronary Vessels - diagnostic imaging | Myocardial Infarction - blood | Predictive Value of Tests | Coronary Thrombosis - diagnosis | Humans | Metals | Middle Aged | Male | Prosthesis Design | Percutaneous Coronary Intervention - instrumentation | Neointima | Prosthesis Failure | Time Factors | Female | Myocardial Infarction - etiology | Stents | Myocardial Infarction - diagnosis | Coronary Vessels - pathology | Drug-Eluting Stents | Cross-Sectional Studies | Tomography, Optical Coherence | Biomarkers - blood | Chi-Square Distribution | Coronary Thrombosis - pathology | Coronary Angiography | Creatine Kinase, MB Form - blood | Aged | Coronary Thrombosis - etiology | Percutaneous Coronary Intervention - adverse effects | Rupture, Spontaneous
Journal Article
Catheterization and Cardiovascular Interventions, ISSN 1522-1946, 07/2006, Volume 68, Issue 1, pp. 83 - 88
Stent thrombosis is a rare but potentially fatal complication of percutaneous treatment of coronary disease. Its occurrence after drug eluting stent (DES)...
positive remodeling | late thrombosis | drug‐eluting stents | Late thrombosis | Positive remodeling | Drug-eluting stents | INTRAVASCULAR ULTRASOUND ANALYSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | drug-eluting stents | STENOSIS | IMPLANTATION | PREDICTORS | APPOSITION | POOLED ANALYSIS | MALAPPOSITION | CORONARY-ARTERY | Coronary Vessels - drug effects | Coronary Vessels - pathology | Humans | Middle Aged | Ultrasonography, Interventional | Paclitaxel - adverse effects | Male | Angioplasty, Balloon, Coronary - adverse effects | Coronary Angiography | Sirolimus - administration & dosage | Time Factors | Adult | Coronary Thrombosis - etiology | Paclitaxel - administration & dosage | Stents - adverse effects | Myocardial Infarction - etiology | Sirolimus - adverse effects
positive remodeling | late thrombosis | drug‐eluting stents | Late thrombosis | Positive remodeling | Drug-eluting stents | INTRAVASCULAR ULTRASOUND ANALYSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | drug-eluting stents | STENOSIS | IMPLANTATION | PREDICTORS | APPOSITION | POOLED ANALYSIS | MALAPPOSITION | CORONARY-ARTERY | Coronary Vessels - drug effects | Coronary Vessels - pathology | Humans | Middle Aged | Ultrasonography, Interventional | Paclitaxel - adverse effects | Male | Angioplasty, Balloon, Coronary - adverse effects | Coronary Angiography | Sirolimus - administration & dosage | Time Factors | Adult | Coronary Thrombosis - etiology | Paclitaxel - administration & dosage | Stents - adverse effects | Myocardial Infarction - etiology | Sirolimus - adverse effects
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2011, Volume 57, Issue 4, pp. 390 - 398
Objectives The purpose of this study was to assess the mechanism(s) of late stent thrombosis (LST) and vascular healing responses in first-generation polymeric...
Cardiovascular | Internal Medicine | drug-eluting stent | pathology | malapposition | vascular response | stent thrombosis | late stent thrombosis | SES | bare-metal stent(s) | DES | paclitaxel-eluting stent(s) | sirolimus-eluting stent(s) | BMS | LST | drug-eluting stent(s) | PES | TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | BARE-METAL | FOLLOW-UP | IMPLANTATION | DEGRADATION-PRODUCTS | APPOSITION | RESTENOSIS | INTRAVASCULAR ULTRASOUND | ASSOCIATION | INSIGHTS | Angioplasty, Balloon, Coronary - instrumentation | Paclitaxel - pharmacology | Humans | Middle Aged | Male | Drug-Eluting Stents - adverse effects | Coronary Thrombosis - diagnostic imaging | Prosthesis Failure | Time Factors | Coronary Restenosis - mortality | Adult | Female | Registries | Coronary Restenosis - etiology | Coronary Stenosis - diagnostic imaging | Coronary Thrombosis - mortality | Coronary Stenosis - therapy | Risk Assessment | Angioplasty, Balloon, Coronary - methods | Coronary Restenosis - diagnostic imaging | Sirolimus - pharmacology | Radiography | Survival Analysis | Aged | Coronary Thrombosis - etiology | Medical colleges | Rapamycin | Thrombosis | Stent (Surgery) | Blood clot | Paclitaxel | Angina pectoris | Stents | Patients
Cardiovascular | Internal Medicine | drug-eluting stent | pathology | malapposition | vascular response | stent thrombosis | late stent thrombosis | SES | bare-metal stent(s) | DES | paclitaxel-eluting stent(s) | sirolimus-eluting stent(s) | BMS | LST | drug-eluting stent(s) | PES | TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | BARE-METAL | FOLLOW-UP | IMPLANTATION | DEGRADATION-PRODUCTS | APPOSITION | RESTENOSIS | INTRAVASCULAR ULTRASOUND | ASSOCIATION | INSIGHTS | Angioplasty, Balloon, Coronary - instrumentation | Paclitaxel - pharmacology | Humans | Middle Aged | Male | Drug-Eluting Stents - adverse effects | Coronary Thrombosis - diagnostic imaging | Prosthesis Failure | Time Factors | Coronary Restenosis - mortality | Adult | Female | Registries | Coronary Restenosis - etiology | Coronary Stenosis - diagnostic imaging | Coronary Thrombosis - mortality | Coronary Stenosis - therapy | Risk Assessment | Angioplasty, Balloon, Coronary - methods | Coronary Restenosis - diagnostic imaging | Sirolimus - pharmacology | Radiography | Survival Analysis | Aged | Coronary Thrombosis - etiology | Medical colleges | Rapamycin | Thrombosis | Stent (Surgery) | Blood clot | Paclitaxel | Angina pectoris | Stents | Patients
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 369, Issue 9562, pp. 667 - 678
Summary Background Stent thrombosis is a safety concern associated with use of drug-eluting stents. Little is known about occurrence of stent thrombosis more...
Internal Medicine | DIABETIC-PATIENTS | MEDICINE, GENERAL & INTERNAL | CIGARETTE-SMOKING | MYOCARDIAL-INFARCTION | REAL-WORLD | LATE ANGIOGRAPHIC STENT | STANDARD STENT | HOSPITAL RESEARCH REGISTRY | BARE-METAL STENT | ANTIPLATELET THERAPY | ARTERY-DISEASE | Myocardial Infarction - mortality | Sirolimus - therapeutic use | Humans | Middle Aged | Male | Paclitaxel - therapeutic use | Angioplasty, Balloon, Coronary | Randomized Controlled Trials as Topic | Anti-Bacterial Agents - therapeutic use | Multicenter Studies as Topic | Time Factors | Coronary Thrombosis - complications | Coronary Thrombosis - prevention & control | Survival Analysis | Female | Coronary Thrombosis - etiology | Stents - adverse effects | Myocardial Infarction - etiology | Cohort Studies | Care and treatment | Usage | Paclitaxel | Coronary thrombosis | Research | Health aspects | Stent (Surgery) | Heart attacks | Hospitals | Radiation therapy | Stents
Internal Medicine | DIABETIC-PATIENTS | MEDICINE, GENERAL & INTERNAL | CIGARETTE-SMOKING | MYOCARDIAL-INFARCTION | REAL-WORLD | LATE ANGIOGRAPHIC STENT | STANDARD STENT | HOSPITAL RESEARCH REGISTRY | BARE-METAL STENT | ANTIPLATELET THERAPY | ARTERY-DISEASE | Myocardial Infarction - mortality | Sirolimus - therapeutic use | Humans | Middle Aged | Male | Paclitaxel - therapeutic use | Angioplasty, Balloon, Coronary | Randomized Controlled Trials as Topic | Anti-Bacterial Agents - therapeutic use | Multicenter Studies as Topic | Time Factors | Coronary Thrombosis - complications | Coronary Thrombosis - prevention & control | Survival Analysis | Female | Coronary Thrombosis - etiology | Stents - adverse effects | Myocardial Infarction - etiology | Cohort Studies | Care and treatment | Usage | Paclitaxel | Coronary thrombosis | Research | Health aspects | Stent (Surgery) | Heart attacks | Hospitals | Radiation therapy | Stents
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 01/2017, Volume 10, Issue 1, pp. 38 - 41
Journal Article
European Heart Journal, ISSN 0195-668X, 05/2010, Volume 31, Issue 10, pp. 1172 - 1180
Late stent malapposition (LSM) may be acquired (LASM) or persistent. LSM may play a role in patients who develop late stent thrombosis (ST). Our objective was...
Late stent thrombosis | Late stent malapposition | Drug-eluting stents | Meta-analysis | INTRAVASCULAR ULTRASOUND ANALYSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | II TRIAL | RANDOMIZED CLINICAL-TRIALS | CORONARY-THROMBOSIS | LESIONS | FUTURE-I | DOUBLE-BLIND | APPOSITION | SIROLIMUS | Humans | Middle Aged | Risk Factors | Prosthesis Failure - adverse effects | Male | Drug-Eluting Stents - adverse effects | Randomized Controlled Trials as Topic | Sirolimus - administration & dosage | Coronary Artery Disease - therapy | Tubulin Modulators - administration & dosage | Female | Aged | Paclitaxel - administration & dosage | Stents - adverse effects | Graft Occlusion, Vascular
Late stent thrombosis | Late stent malapposition | Drug-eluting stents | Meta-analysis | INTRAVASCULAR ULTRASOUND ANALYSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | II TRIAL | RANDOMIZED CLINICAL-TRIALS | CORONARY-THROMBOSIS | LESIONS | FUTURE-I | DOUBLE-BLIND | APPOSITION | SIROLIMUS | Humans | Middle Aged | Risk Factors | Prosthesis Failure - adverse effects | Male | Drug-Eluting Stents - adverse effects | Randomized Controlled Trials as Topic | Sirolimus - administration & dosage | Coronary Artery Disease - therapy | Tubulin Modulators - administration & dosage | Female | Aged | Paclitaxel - administration & dosage | Stents - adverse effects | Graft Occlusion, Vascular
Journal Article
International Heart Journal, ISSN 1349-2365, 2018, Volume 59, Issue 1, pp. 209 - 212
A 43-year-old man was admitted to our hospital with ST-segment elevation acute coronary syndrome. He had experienced myocardial infarction 19 months...
Acute coronary syndrome | Late stent malapposition | Incomplete neointimal stent coverage | CARDIAC & CARDIOVASCULAR SYSTEMS | NEOATHEROSCLEROSIS | MALAPPOSITION | RISK | INTRAVASCULAR ULTRASOUND | COHERENCE TOMOGRAPHY | Occlusion | Myocardial infarction | Medical imaging | Heart attacks | Angiography | Implants | Coronary artery | Electrocardiography | Ultrasound | Stents | Thrombosis
Acute coronary syndrome | Late stent malapposition | Incomplete neointimal stent coverage | CARDIAC & CARDIOVASCULAR SYSTEMS | NEOATHEROSCLEROSIS | MALAPPOSITION | RISK | INTRAVASCULAR ULTRASOUND | COHERENCE TOMOGRAPHY | Occlusion | Myocardial infarction | Medical imaging | Heart attacks | Angiography | Implants | Coronary artery | Electrocardiography | Ultrasound | Stents | Thrombosis
Journal Article